Hi Ice,
I took you off ignore to see if you had provided any insightful research or meaningful contribution to the forum.
There are a number of top 20 holders that have been on the extended journey Ice. A few of us on HC as well, funny that.
Plus the top twenty holders I am in regular contact with (6) and plenty of other large holders I interact with very regularly know all too well the proper value of this company. As does Management, BOD and the Ad Board.
Plus a 240% SP gain in a 12 month period is a reasonable start to our long term re rate.
Consolidations have not killed this company at all. The company is very much alive as anyone who has read the last few announcements would know.
Anteris will not be sold for much less than what it is worth.
Lets talk just before Christmas and see where we stand.
Ann: Chief Medical Officer Appointment, page-38
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
-0.300(1.64%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.29 | $18.30 | $17.65 | $181.7K | 10.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30 | $17.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.00 | 499 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |